Published in Hepatitis Weekly, September 17th, 2001
Chronic hepatitis C patients enrolled in a multicenter study in Japan who received zinc supplements with interferon fared better after 24 weeks of IFN treatments than patients who received IFN therapy but who did not take zinc, according to a report by Hitoshi Takagi and colleagues, Gunma University School of Medicine, Japan, in Journal of Viral Hepatitis.
Zinc supplementation reportedly prevents some viruses from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.